← Browse by Condition
Medical Condition
her2
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2
NCT06253871 Phase 1
Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Enrollment
243 pts
Location
United States, Franc...
Sponsor
Iambic Therapeutics, Inc
NCT05957757 Phase 2
Recruiting
RC48 Combined With Tislelizumab for Bladder Sparing Treatment in NMIBC With BCG Treatment Failure and HER2 Expression
Enrollment
20 pts
Location
China
Sponsor
RenJi Hospital